These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

493 related articles for article (PubMed ID: 7168371)

  • 1. Leukocyte migration inhibition (LMI) by a specific antigen in human toxoplasmosis.
    Ferencz A; Nyerges G; Jankó M
    Acta Microbiol Acad Sci Hung; 1982; 29(3):209-11. PubMed ID: 7168371
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Problems and limitations of conventional and innovative methods for the diagnosis of Toxoplasmosis in humans and animals].
    Piergili Fioretti D
    Parassitologia; 2004 Jun; 46(1-2):177-81. PubMed ID: 15305712
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Toxoplasmosis: comparative serological diagnosis (direct agglutination, complement fixation, hemagglutination inhibition tests) in order to attempt to clarify the diverse periods of infection in man].
    Mastracchio G; Martinetto P; Savoia D
    G Batteriol Virol Immunol; 1983; 76(1-6):62-103. PubMed ID: 6679482
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Verification of tween-ether antigen for complement fixation test in the diagnostics of toxoplasmosis.
    Pokorný J; Frühbauer Z; Curík B; Zástĕra M
    J Hyg Epidemiol Microbiol Immunol; 1979; 23(3):353-6. PubMed ID: 575152
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Leukocyte migration inhibition by a specific antigen in human typhoid fever.
    Nyerges G; Szerdahelyi F; Tankó S; Bognár S; Funk O
    Acta Microbiol Acad Sci Hung; 1976; 23(3):293-7. PubMed ID: 1020698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A new complement fixation test for toxoplasmosis. Comparison with other serological methods.
    Filice G; Carnevale G; Meroni V; Parisi A; Passarani N
    Boll Ist Sieroter Milan; 1981 May; 60(2):129-36. PubMed ID: 7030360
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The diagnostic significance of the indirect hemagglutination test for the surveillance of toxoplasmosis during pregnancy (author's transl)].
    Picher O; Aspöck H
    Wien Med Wochenschr; 1981 Jan; 131(1):14-22. PubMed ID: 7013281
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Diagnosis of toxoplasmosis by indirect hemagglutination. II. Value of mixed total antigen fixation in the presence of glutaraldehyde in the early diagnosis of the disease].
    Senet JM; Robert R; Mauras G
    Biomedicine; 1976 Jul; 25(6):212-4. PubMed ID: 822893
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison between the complement fixation test LBCF-H100-TTE, IHAT and IgM-IFAT performed on pure IgM fractions in acute acquired and congenital toxoplasmosis.
    Filice G; Carnevale G; Meroni V; Gorini G; Carosi G
    Boll Ist Sieroter Milan; 1982; 61(3):235-8. PubMed ID: 6927251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic information from serological tests in human toxoplasmosis. II Evolutive study of antibodies and serological patterns in acquired toxoplasmosis, as detected by hemagglutination, complement fixation, IgG and IgM-immunofluorescence tests.
    Camargo ME; Leser PG
    Rev Inst Med Trop Sao Paulo; 1976; 18(4):227-38. PubMed ID: 788114
    [No Abstract]   [Full Text] [Related]  

  • 11. Use of the microprecipitation method in agar gel (MPA) in the diagnostics of toxoplasmosis. 3. Correlation of MPA, complement-fixation reaction (CFT) and Sabin-Feldman's dye test (SFT) in serodiagnosis of human toxoplasmosis.
    Hübner J; Uhlíková M
    J Hyg Epidemiol Microbiol Immunol; 1973; 17(1):70-84. PubMed ID: 4196795
    [No Abstract]   [Full Text] [Related]  

  • 12. Correlation of in vitro and in vivo tests for cell-mediated immunity in the dog.
    Thilsted JP; Shifrine M; Wiger N
    Am J Vet Res; 1979 Sep; 40(9):1313-5. PubMed ID: 525939
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell-mediated immunoreactivity in acute human trichinellosis.
    Ferencz A; Nyerges G; Mislóczky M
    Acta Microbiol Hung; 1983; 30(1):47-51. PubMed ID: 6659853
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Study of the cellular basis hypersensitivty in human toxoplasmosis by means of the M.I.T. test (leukocyte migration inhibition test)].
    Del Rey Calero J; Calbo Torrecillas F; Rodrĩguez Salinas MC
    Rev Clin Esp; 1972 Jun; 125(6):485-90. PubMed ID: 4641542
    [No Abstract]   [Full Text] [Related]  

  • 15. [The antigenic structure of Toxoplasma gondii. III. Behavior of human sera as compared with purified antigens].
    Spanó C; LA Rosa G; LA Licata R
    Boll Ist Sieroter Milan; 1975; 54(1):36-44. PubMed ID: 1125110
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Serology of toxoplasmosis: review of tests currently in use for diagnosis and prevention].
    Ferrucci M
    Quad Sclavo Diagn; 1980 Jun; 16(2):176-92. PubMed ID: 7017796
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Simplified in vitro method for measuring delayed hypersensitivity to latent intracellular infection in man (toxoplasmosis).
    Gaines JD; Araujo FG; Krahenbuhl JL; Remington JS
    J Immunol; 1972 Jul; 109(1):179-82. PubMed ID: 5035243
    [No Abstract]   [Full Text] [Related]  

  • 18. [Comparative studies of the Sabin-Feldman and immunofluorescence tests for toxoplasma antibodies (author's transl)].
    Fuhr R
    Dtsch Med Wochenschr; 1974 May; 99(18):949-52. PubMed ID: 4599848
    [No Abstract]   [Full Text] [Related]  

  • 19. [Use of the ISAGA method in detection of specific IgM, IgA, IgE antibodies in acquired and congenital toxoplasmosis].
    Paul M
    Wiad Parazytol; 1997; 43(1):39-51. PubMed ID: 9289926
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A new indirect hemagglutination test in the determination of anti-toxoplasma antibodies].
    Duvina PL; Santalena G; Simoni MR; Pieroni O; Pieruccini G
    Minerva Pediatr; 1979 May; 31(9):689-98. PubMed ID: 379584
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 25.